Aschenbrenner, Diane S.2017-09-272017-09-272015-01Aschenbrenner, D. S. (2015). New treatment for opioid-induced constipation. AJN American Journal of Nursing, 115(1), 23. doi:10.1097/01.NAJ.0000459622.00045.fdhttp://dx.doi.org/10.1097/01.NAJ.0000459622.00045.fdhttp://hdl.handle.net/11603/5655The opioid antagonist naloxegol (Movantik) is now approved to treat opioid-induced constipation in adults with chronic noncancer pain. The most common adverse effects are abdominal pain, diarrhea, nausea, flatulence, vomiting, and headache.1 pageen-USText